(Q35608658)

English

Rosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPARγ- and PPARδ-Dependent Phosphorylation of Akt and eNOS.

scientific article published on 22 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

Rosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPARγ- and PPARδ-Dependent Phosphorylation of Akt and eNOS. (English)

1 reference

Europe PubMed Central

9 August 2017

0 references

metabolic syndrome

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

author name string

Zhigang Zhao

1

1 reference

Europe PubMed Central

9 August 2017

Zhidan Luo

2

1 reference

Europe PubMed Central

9 August 2017

Peijian Wang

3

1 reference

Europe PubMed Central

9 August 2017

Jing Sun

4

1 reference

Europe PubMed Central

9 August 2017

Hao Yu

5

1 reference

Europe PubMed Central

9 August 2017

Tingbing Cao

6

1 reference

Europe PubMed Central

9 August 2017

Yinxing Ni

7

1 reference

Europe PubMed Central

9 August 2017

Jing Chen

8

1 reference

Europe PubMed Central

9 August 2017

Zhencheng Yan

9

1 reference

Europe PubMed Central

9 August 2017

Daoyan Liu

10

1 reference

Europe PubMed Central

9 August 2017

Zhiming Zhu

11

1 reference

Europe PubMed Central

9 August 2017

publication date

22 November 2011

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

2011

1 reference

Europe PubMed Central

9 August 2017

291656

1 reference

Europe PubMed Central

9 August 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Rapid effect of single-dose rosiglitazone treatment on endothelial function in healthy men with normal glucose tolerance: data from a randomised, placebo-controlled, double-blind study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Oral intake of rosiglitazone promotes a central antihypertensive effect via upregulation of peroxisome proliferator-activated receptor-gamma and alleviation of oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor beta agonists via the phosphatidyl-inositol-3 kinase-Akt pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Peroxisome proliferator-activated receptor gamma (PPARgamma): Is the genomic activity the only answer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Rosiglitazone reduces blood pressure in female Dahl salt-sensitive rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Disruption of endothelial peroxisome proliferator-activated receptor-gamma reduces vascular nitric oxide production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Peroxisome proliferator-activated receptors in the cardiovascular system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

27 July 2018

Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

Treatment of spontaneously hypertensive rats with rosiglitazone and/or enalapril restores balance between vasodilator and vasoconstrictor actions of insulin with simultaneous improvement in hypertension and insulin resistance.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

Effect of rosiglitazone on factors related to endothelial dysfunction in patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

Rosiglitazone attenuates endothelin-1-induced vasoconstriction by upregulating endothelial expression of endothelin B receptor.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-indepen

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

PPAR-delta in Vascular Pathophysiology

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

Insulin-stimulated endothelial nitric oxide release is calcium independent and mediated via protein kinase B.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

Vascular insulin resistance in prehypertensive rats: role of PI3-kinase/Akt/eNOS signaling

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

Rosiglitazone stimulates nitric oxide synthesis in human aortic endothelial cells via AMP-activated protein kinase.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1α and PPARβ/δ gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

Augmentation of nitric oxide is crucial for the time-dependent effects of rosiglitazone on blood pressure and baroreflex function in rats

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F291656

21 January 2018

Rationale and design of the Glitazones and the Endothelium (GATE) study: evaluation of rosiglitazone on endothelial function in patients with diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236323

25 September 2018

Effect of Rosiglitazone on Endothelial Function and Inflammatory Markers in Patients With the Metabolic Syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190906

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adiponectin is associated with improvement of endothelial function after rosiglitazone treatment in non-diabetic individuals with metabolic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190906

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190906

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PPARdelta and PGC1alpha act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190906

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone prevents free fatty acid-induced vascular endothelial dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190906

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2011/291656

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35608658&oldid=1801494568"